First-Line Pembrolizumab Plus Chemotherapy for Advanced Nonsquamous NSCLC - 102164

Spotlight
Video

First-Line Pembrolizumab Plus Chemotherapy for Advanced Nonsquamous NSCLC

Loading........
Description: H. Jack West, MD of Swedish Cancer Institute discusses the updated results of the KEYNOTE-021 study for patients with advanced nonsquamous non-small cell lung cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 9094: First-line carboplatin and pemetrexed (CP) with or without pembrolizumab (pembro) for advanced nonsquamous NSCLC: Updated results of KEYNOTE-021 cohort G.
Shared By : AnnualMeeting2017
Posted on : 06/16/17
Added : 1 year ago